Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ewing Sarcoma
Transformation induced by EWS/FLI-I can be suppressed by KRAB/FLI-I
April 22nd, 2003
The chimeric transcription factor EWS/FLI-I of Ewing sarcoma can be suppressed by KRAB/FLI-I, leading to reversal of transformed phenotype. According to a study from Australia, "Ewing sarcoma is a childhood bone tumor with poor prognosis, most commonly associated with a t(11;22)(q24;q12) reciprocal translocation that fuses the EWS and FLI-1 genes, resulting in the production of an aberrant chimeric transcription factor EWS/FLI-1. "To elucidate the mechanisms by which EWS/FLI-1 mediates transformation in mouse models, we have generated a murine Ews/Fli-1 fusion protein. We demonstrate that this protein transforms fibroblast cells in vitro similar to...
Source: Cancer Weekly (2003-04-22)
|
